Statistics
Publications
6
Citations
589
H-Index
6
Active since
2018
Dimitrios Doultsinos is an author at Université de Rennes specializing in molecular oncology, medicine, and oncology.
Publications per year
2018–2023
6
6
Spatially resolved clonal copy number alterations in benign and malignant tissue
Andrew Erickson, Mengxiao He, Emelie Berglund et al. · Nature · 2022 · 318 citations · Full text
Dual IRE1 RNase functions dictate glioblastoma development
Stéphanie Lhomond, Tony Avril, Nicolas Dejeans et al. · EMBO Molecular Medicine · 2018 · 170 citations · Full text
Medicine, Biochemistry, Oncology +17
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment
Diana Pelizzari‐Raymundo, Dimitrios Doultsinos, Raphaël Pineau et al. · iScience · 2023 · 37 citations · Full text
Medicine, Oncology, Pharmacology +15
Peptidomimetic‐based identification of FDA‐approved compounds inhibiting IRE1 activity
Dimitrios Doultsinos, Antonio Carlesso, Chetan Chintha et al. · FEBS Journal · 2020 · 29 citations · Full text
Medicine, Oncology, Pharmacology +16
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells
Qiang Hu, Ninu Poulose, Samuel Girmay et al. · RNA Biology · 2021 · 21 citations · Full text
1–5 of 6